Clinical Hospital Colentina

Bucharest, Romania

Clinical Hospital Colentina

Bucharest, Romania
Time filter
Source Type

Berceanu D.,Clinical Emergency Hospital of Bucharest | Bucur D.,Clinical Hospital Colentina | Diaconu C.,Clinical Emergency Hospital of Bucharest | Diaconu C.,Carol Davila University of Medicine and Pharmacy
Archives of the Balkan Medical Union | Year: 2016

Patients with diabetes have a high prevalence of liver disease. The entire spectrum of liver disease is seen in patients with type 2 diabetes. Non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes (T2DM) are common conditions that regularly co-exist and act synergistically to drive negative outcomes. The classical pathway consists of initial insulin resistance, increased lipolysis, lipid accumulation in the hepatocytes, oxidative stress, and cell damage followed by fibrosis. Insulin resistance is a characteristic feature of NAFLD, as a result of increased secretion of specific proinflammatory cytokines such as TNF- . NAFLD does not always progress to NASH, and the precise pathological events leading to steatohepatitis are yet to be determined. There is an under-recognized role of diabetes in many patients with cryptogenic cirrhosis. The prevalence of hepatocellular carcinoma is increased in patients with diabetes as well the prevalence of diabetes in patients with hepatocellular carcinoma. Patients with chronic hepatitis C are more likely to develop diabetes; all patients with type 2 diabetes and persistently elevated serum ALT should be screened for HCV testing. The majority of patients with NAFLD do not require a specific treatment. The treatment of NAFLD consists of lifestyle modification as well as pharmacological therapy. Hepatic steatosis diminishes in parallel with weight loss. Thiazolidinediones are emerging as the treatment of choice even in the absence of diabetes. © 2016 CELSIUS.

Niaa G.R.,Chronic Disease Hospital St Luke | Omer S.,St Ioan Emergency Hospital | Radoi M.,Bagdasar Arseni Emergency Hospital | Popescu M.,Clinical Hospital Colentina | And 3 more authors.
Archives of the Balkan Medical Union | Year: 2015

Background: Numerous studies have focused on evaluating illness perceptions in patients with cancer and its influence on cope and disease adaptation, observing that changing the cognitive representation of the disease may lead to increase the patients quality of life. Objective: Illness perception may differ in young patients compared to elderly patients, the latter being influenced by the affective memory or associated chronic diseases and their outcomes. Materials and methods: Elderly patients with cancer were evaluated on admission in Oncology-Palliative Care Departement, using Brief Illness Perceptions Questionnaire. Results and discussions: The results showed that the majority of elderly patients shows an average perceptions of the disease, very few shows low illness perceptions and identified as causal factors: stress, smoking and food. Conclusions: To increase the quality of life of elderly patients with cancer may require early assessment of illness perceptions and early psychoemotional, social and spiritual interventions.

Capitanescu C.,Science Ecodet Activ S. R. L | Capitanescu C.,U.S. Environmental Protection Agency | Macovei Oprescu A.M.,Carol Davila University of Medicine and Pharmacy | Supeanu A.,Romanian National Sanitary Veterinary and Food Safety Authority | And 5 more authors.
Journal of Enzyme Inhibition and Medicinal Chemistry | Year: 2016

The finding of the most appropriate way to assess precisely the antivenom efficacy represents one of the major issues for antivenom standardization and success increasing of antivenom therapy. The efficacy of experimental Vipera ammodytes antivenom raised in sheep was determined using in vivo mouse lethality test, respectively, L-aminoacid oxidase, total proteinase and phospholipase A2 antienzymatic effectiveness. The values gained for the antivenom potency depend on the method of measure. So, some of the most toxic venom proteins own phospholipase A2 activity and provide the highest antivenom potency (lowest effective dose) values by antienzymatic assay method. This value is similar with total antiproteolytic antivenom potency value, but almost three times higher than value obtained by L-aminoacid oxidase (low toxic viper venom protein) antienzymatic assay method. © 2016 Informa UK Limited, trading as Taylor & Francis Group.

Trifu V.,Central Emergency Clinical Military Hospital Dr Carol Davila | Tiplica G.-S.,Clinical Hospital Colentina | Naumescu E.,Clinical Hospital Of Dermato Venerology Prof Dr Scarlat Longhin | Moro L.,Cosmo Oil Co. | Celasco G.,Cosmo Research and Development S.p.A.
British Journal of Dermatology | Year: 2011

Background Acne vulgaris is a disorder of the pilosebaceous unit in which the androgens contribute to its onset and persistence. The use of antiandrogens is therefore potentially effective; however, antiandrogens for topical use are not available on the market. Cortexolone 17α-propionate (CB-03-01; Cosmo S.p.A, Lainate, Italy) is a new potent topical antiandrogen potentially useful in acne vulgaris. Objectives To evaluate the safety and the topical efficacy of CB-03-01 1% cream in acne vulgaris as compared with placebo and with tretinoin 0·05% cream (Retin-A®; Janssen-Cilag). Methods Seventy-seven men with facial acne scored 2-3 according to Investigator's Global Assessment (IGA) were randomized to receive placebo cream (n = 15), or CB-03-01 1% cream (n = 30), or tretinoin 0·05% cream (n = 32) once a day at bedtime for 8 weeks. Clinical efficacy was evaluated every 2 weeks including total lesion count (TLC), inflammatory lesion count (ILC), acne severity index (ASI) and IGA. Safety assessment included local irritancy score, laboratory tests, physical examination, vital signs and recording of adverse events. Results CB-03-01 1% cream was very well tolerated, and was significantly better than placebo regarding TLC (P = 0·0017), ILC (P = 0·0134) and ASI (P = 0·0090), and also clinically more effective than comparator. The product also induced a faster attainment of 50% improvement in all the above parameters. Conclusions This pilot study supports the rationale for the use of topical antiandrogens in the treatment of acne vulgaris. CB-03-01 1% cream seems to fit with the profile of an ideal antiandrogen for topical use. © 2011 The Authors. BJD © 2011 British Association of Dermatologists 2011.

Daniela G.G.,Clinical Hospital Colentina | Mihaela P.,Clinical Hospital Colentina | Mihaela T.,Clinical Hospital Colentina | Meilin M.,Clinical Hospital Colentina | And 2 more authors.
Therapeutics, Pharmacology and Clinical Toxicology | Year: 2014

Nausea is an unpleasant sensation associated with aversion to food and impending feeling of vomiting. Vomiting represent the oral expulsion of gastric contents, and is preceded or not by nausea. In hemato - oncology, there are multiple etiological factors of emesis. The antiemetic measures imply to identify and treat reversible causes. Antiemetic drugs can be classified as: Antiemetics acting on the central nervous system and double-acting antiemetics. Chemotherapeutic regimens used in the treatment of hematologic and non-hematologic malignancies are accompanied by a degree of emesis. Corroborating the data in the literature, individualized approach is required in the antiemetic treatment adapted to each patient, current guidelines directing the clinician in deciding on the anti-emetic prophylaxis. We analyzed a group of 17 patients aged between 20 and 83 years, eight men and nine women, undergoing cytostatic chemotherapy for hematological and non-hematologic malignancies, hospitalized in the Hematology Department of Clinical Hospital "Colentina" and the Department of Oncology and Palliative Care, Chronic Disease Hospital "St. Luke" from Bucharest. Patient selection was based on the type of chemotherapy, being selected mainly patients undergoing moderate or high emetogenic chemotherapy. In Table 1 there are presented patient characteristics: Age, sex, diagnoses, type of diet, anti-emetic scheme, the degree of emesis and the occurrence of adverse reactions to antiemetic therapy. There are presented the conclusions on the use of Palonosetron in the analyzed patients (Table 2). The therapy was well tolerated with no significant side effects and the drug efficiency conforms to the data in the literature, both for hematological and non-hematological malignancies. Conclusions: Anti-emetic prophylaxis is a challenge for clinicians. Beyond current developments, nausea and vomiting after chemotherapy are still the major factors affecting quality of life and compliance with treatment. The Scientific Committees of developing international guidelines are being debated on the strict formal recommendations for the use of antiemetics associated to chemotherapy treatments.

Croitoru A.,National Institute of Pneumology | Ionita D.,Spitalul Universitar Of Urgenta Elias | Stroescu C.,National Institute of Pneumology | Pele I.,National Institute of Pneumology | And 5 more authors.
Pneumologia | Year: 2013

Background: Respiratory rehabilitation programs (RR) are essential tools in the management of COPD. Aim: We present the results of a 7-week outpatient rehabilitation program in terms of dyspnea, exercise tolerance and quality of life. Material and method: The following parameters were evaluated before and after RR: dyspnea (mMRC scale), pulmonary function (FEV1, RV - residual volume), exercise tolerance (6MWT - 6 minutes walk test, CPET - cardiopulmonary exercise test), quality of life (SGRQ questionnaire). The RR program was outpatient, hospital based (7 weeks, 3 sessions/week) and included: exercise training, therapeutic education, and psychological support. Results: 25 patients, COPD stage II-IV GOLD (mean FEV1 44.5 ± 13% predicted), mean age 60.4 ±12 years, 7 females, average BMI 27.14±4 kg/m2, average RV residual volume 221.55±86% predicted. Mean 6MWT distance: 407.48 ± 84 m and mean maximum power (Pmax) obtained on CPET: 75.67±30 Watts. All patients were symptomatic with significant dyspnea (3.06±0.7 on mMRC scale) and showed a significant impairment of quality of life: SGRQ score 46.23±14. At the end of RR program: dyspnea decreased with 0.67 points on mMRC scale (p = 0.000), 6MWT distance increased with 58.5 m (p = 0.001), Pmax obtained during CPET increased with 11.2 W, without reaching statistical significance (p>0.05). SGRQ score decreased by 5.59 points (p = 0.02). There were no significant improvements in FEV1 and RV values (p>0.05). Conclusion: In our COPD patients, the 7 week outpatient rehabilitation program was effective, leading to improvement of symptoms, exercise tolerance and quality of life.

Tanasescu C.,Clinical Hospital Colentina | Madalina I.,Emergency Hospital | Carmen C.M.,University of Bucharest | Marcela P.,University of Bucharest
Therapeutics, Pharmacology and Clinical Toxicology | Year: 2011

Background: Since its discovery in 1982, Helicobacter pylori infection is recognized as a major cause of gastro-intestinal diseases, including chronic gastritis, peptic ulcer disease and gastric malignancy. Its prevalence is connected to socio-economical conditions and most of the individuals are infected during childhood. Regarding Helicobacter pylori treatment, a combination of antibiotics must be given but in certain cases repeated courses of different antibiotics are needed to eradicate H. pylori. Eradicating H. pylori is still a problem because of the rapidly increasing prevalence of multidrug resistant strains worldwide. Aim: In this study we want to emphasize the need for culturing Helicobacter pylori for certain cases and to show the resistance rate to different antibiotics. The samples for culture were obtained either by gastric biopsy taken by upper GI endoscopy or by enterotest - a string test with a small capsule swallowed and removed after 1 hour. For the positive cultures, an antibiotic susceptibility was performed. Some of the empirically used antibiotics showed surprisingly an increased rate of resistance. Materials and methods: We have selected just the patients resistant to the first line therapy (in our case, Clarithromycin 500 mg bid, Amoxicillin, 1g bid and a Pump Proton Inhibitory drug 20 mg bid) dividing them in two groups. For one group gastric biopsy was done and for the other group, enterotest was performed. The samples taken from gastric biopsy and enterotest were put on special media (pylori agar) with microaerophilia for cultivation. Positive culture was obtained after an incubation of three to seven days. To this culture an antibiogram by diffusion method was done. Results: Positive cultures were obtained in 17 patients (out of 20) from gastric biopsy and in 15 patients (out of 20) from enterotest. Increased resistance in Helicobacter pylori strains was observed for Metronidazole and Clarithromycin, commonly used in first line therapy. On the other side, sensitivity was noticed for: Amoxicillin, Ciprofloxacin, Levofloxacin, Furazolidone, Tetracycline. To the patients, a therapy containing an association of two antibiotics from susceptibility testing and a PPI, was given. A good clinical response and a success rate of 93% at one month after finishing the treatment were obtained. The rest of the patients (7%) were retested by rapid urease test or fecal antigen and if they were still positive a second culture was scheduled. Discussions: Many treatment regimens have been proposed for Helicobacter pylori management. The initial approach should be based on the prevalence of drug resistance-especially to Metronidazole and Clarithromycin. Strict adherence to the treatment should be highly recommended to the patient. Reinfection needs to be avoided by respecting basic hygiene rules. Culture seems the best option for cases resistant to classic therapy. Conclusions: Treating Helicobacter pylori can be a challenge when this proves to be resistant to several antibiotics. In these cases, culturing it by gastric biopsy or less invasive, by Enterotest and performing antibiogram afterwards seems an appropriate solution. Cultures have to be examined after at least 72 hours of incubation and negative results can only be certified after seven days of incubation. Metronidazole, a very used antibiotic in first line therapy has a very high resistance and it should be avoided especially if the patient has taken this for other infections. © 2011.

Serafim A.,Polytechnic University of Bucharest | Petre D.G.,Polytechnic University of Bucharest | Moraru L.,Polytechnic University of Bucharest | Cioflan H.E.,Carol Davila University of Medicine and Pharmacy | And 5 more authors.
Key Engineering Materials | Year: 2014

This work presents the synthesis and characterization of natural-synthetic hydrogels based on gelatin (Gel) and polyvinylpyrrolidone (PVP), with potential for skin grafts applications. The natural component, Gel insures the biocompatibility and biodegradability of the bicomponent system [1], while the synthetic counterpart, PVP, is a physiologic inert component, extensively used in medicine due to its water affinity and due to its capacity of confer elasticity to films and membranes with potential applications in skin grafts [2]. The obtained hydrogels were subjected to morpho-structural analysis and rheological and mechanical tests (traction). The water affinity of the systems was estimated and their capacity to generate porous substrates through freeze-drying was evaluated. © (2015) Trans Tech Publications, Switzerland.

Jianu D.M.,Carol Davila University of Medicine and Pharmacy | Jianu D.M.,ProEstetica Medical Center | Streinu-Cercel A.,Carol Davila University of Medicine and Pharmacy | Blidaru A.,Carol Davila University of Medicine and Pharmacy | And 9 more authors.
GERMS | Year: 2013

Introduction Recent articles have described an endogenous breast flora, particularly in the nipple ducts, with potential implications in the outcome of aesthetic breast surgery. To characterize the ecology of the breast, we designed a study to assess the microbial species identified on the breast skin and parenchyma in patients undergoing breast surgical interventions. Methods After obtaining informed consent and background data on concurrent diseases, previous contact with the hospital system and prior use of antibiotics, samples are collected preoperatively from three areas of the breast skin, bilaterally: the inframammary fold, the areola and the axilla, prior to decontamination. These samples will serve as positive controls and will aid in characterizing the normal breast skin flora. After preoperative decontamination, samples are again collected, to check for any residual bacterial flora and the nipple is sealed with Tegaderm (3M, USA) and betadine ointment, to reduce any putative bacterial load. Intraoperatively, samples are collected from: a) the incision line (dermal level): 1. superficially, 2. medium depth in the breast parenchyma, 3. deep parenchyma, and b) axillary parenchyma (where possible), together with a bioptic fragment. Postoperatively, a second nipple sample is collected. For secondary breast augmentation surgeries, capsular biopsy is also performed (where relevant), and the implants undergo sonication, to allow biofilm identification. In the laboratory, all samples are cultured on blood agar incubated with CO2, cystine lactose electrolyte deficient medium and Sabouraud gentamicin-chloramphenicol agar. For positive culture samples, the number of colonies and their morphologic characteristics are reported. Identification will be carried out with MALDI-TOF and VITEK (bioMérieux, France), yielding automated antibiotic sensitivity profiles. For all germs with sensitivity profiles differing from the wild-type strain, E-tests will be performed. Follow-up information on the postoperative evolution will be collected and analyzed for potential factors predictive of good evolution. Discussion This study will provide important information about the microflora of the breast skin, its sensitivity profile, and the degree of contamination of the nipple ducts and parenchyma, if any, addressing a scientific hypothesis insufficiently explored so far. © GERMS 2013.

Buraga I.,Clinical Hospital Colentina | Antoce L.M.,Clinical Hospital Colentina | Baetu C.,Clinical Hospital Colentina | Dobrescu A.,Clinical Hospital Colentina | And 2 more authors. | Year: 2013

Objective. The main goal of this review is to provide some answers about the best therapy of pregnant women with epilepsy and/or women with epilepsy taking oral contraception. Methods. We have collected information's concerning the problems that may arise before and after a pregnancy, involving the best therapeutically options for a pregnant woman. Results. Women with epilepsy have frequent menstrual disorders, reproductive endocrinological disturbances, ovulatory dysfunction and infertility, presenting a risk of contraceptive failure associated with some antiepileptic. Antiepileptic drugs have some side effects on pregnancy by increasing the rate of abortion, preterm labor and vaginal bleeding, especially in polytherapy. Pregnancy can affect the pharmacokinetics of antiepileptic drugs at any level from absorption, distribution, metabolism, and therefore we have showed a list of the most used antiepileptic and how they can affect a future pregnancy from conceiving until delivery and after. Conclusions. Epilepsy represents a sensible field in relationship with pregnancy that involves contraception, heredity and teratology, especially if we consider that the risk of a convulsive seizure to mother and child is frequently over weighted by a continued therapy.

Loading Clinical Hospital Colentina collaborators
Loading Clinical Hospital Colentina collaborators